Who are BigHat Biosciences's decision-makers?
BigHat is led by CEO and co-founder Peyton Greenside after Mark DePristo stepped down and passed the CEO role to her in 2025.
- CEO
- Peyton Greenside
- CTO/key exec
- Hunter Elliott, VP Machine Learning
- Founded
- 2019
- Employees
- Series B biotech; exact headcount not disclosed
- HQ
- San Mateo, CA
- Notable
- Milliner AI/ML plus wet-lab antibody design platform
- Peyton GreensideCEO and co-founderCEO since 2025; co-founder since 2019Deep learning and computational biology leader.
- Mark DePristoCo-founder; former CEOCEO 2019-2025Former Broad Institute and Google Brain Genomics leader.
- Eddie AbramsChief Information OfficerListed on about pageLeads information systems and technology.
- Hunter ElliottVP, Machine LearningListed on about pageLeads ML function for antibody design.
Who leads BigHat Biosciences?
BigHat is led by CEO and co-founder Peyton Greenside after Mark DePristo stepped down and passed the CEO role to her in 2025.
Who actually makes buying decisions at BigHat Biosciences?
Buying decisions at BigHat Biosciences depend on the offer: product and engineering for technical tools, finance and legal for contracts, security for data/PII, and go-to-market or operations leaders for growth and support products.
How is BigHat Biosciences organized as it scales?
The organization should be treated according to its stage and ownership structure: Series B biotech; exact headcount not disclosed; Private; valuation not publicly disclosed.
As of June 2026.Sources:BigHat aboutPeyton Greenside profile
BigHat Biosciences — frequently asked questions
Read the full BigHat Biosciences profile
More on BigHat Biosciences
Who are BigHat Biosciences's decision-makers — other companies
Revenue work. On autopilot.
Start Free TrialBuilt for revenue teams who care about quality.